Joel Wedd

978 total citations
30 papers, 677 citations indexed

About

Joel Wedd is a scholar working on Hepatology, Epidemiology and Surgery. According to data from OpenAlex, Joel Wedd has authored 30 papers receiving a total of 677 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Hepatology, 13 papers in Epidemiology and 11 papers in Surgery. Recurrent topics in Joel Wedd's work include Liver Disease and Transplantation (13 papers), Liver Disease Diagnosis and Treatment (10 papers) and Hepatocellular Carcinoma Treatment and Prognosis (8 papers). Joel Wedd is often cited by papers focused on Liver Disease and Transplantation (13 papers), Liver Disease Diagnosis and Treatment (10 papers) and Hepatocellular Carcinoma Treatment and Prognosis (8 papers). Joel Wedd collaborates with scholars based in United States, Australia and Spain. Joel Wedd's co-authors include Scott W. Biggins, Avash Kalra, Melissa B. Miller, Jane Gralla, Kiran Bambha, Rachel E. Patzer, Peter H. Gilligan, Margaret W. Leigh, Marianne S. Muhlebach and Amelia F. Drake and has published in prestigious journals such as Journal of Clinical Oncology, Hepatology and Journal of Clinical Microbiology.

In The Last Decade

Joel Wedd

28 papers receiving 667 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Joel Wedd United States	17	319	292	245	140	87	30	677
Evelyn Hsu United States	17	314 1.0×	160 0.5×	417 1.7×	169 1.2×	95 1.1×	70	768
Hin Hin Ko Canada	13	293 0.9×	323 1.1×	236 1.0×	102 0.7×	34 0.4×	54	786
Piotr Małkowski Poland	17	430 1.3×	338 1.2×	283 1.2×	40 0.3×	104 1.2×	97	771
N Bar-Nathan Israel	16	244 0.8×	213 0.7×	300 1.2×	125 0.9×	158 1.8×	49	697
Mohamed A. Hassan United States	14	410 1.3×	420 1.4×	138 0.6×	51 0.4×	61 0.7×	62	881
Nyingi Kemmer United States	20	791 2.5×	649 2.2×	390 1.6×	37 0.3×	90 1.0×	65	1.1k
Carolina Rumbo Argentina	13	281 0.9×	274 0.9×	226 0.9×	36 0.3×	84 1.0×	46	614
T. Pruett United States	15	232 0.7×	342 1.2×	293 1.2×	59 0.4×	260 3.0×	26	766
Vijaya Srinivasan India	10	145 0.5×	128 0.4×	131 0.5×	57 0.4×	31 0.4×	26	371
Mayur Brahmania Canada	14	234 0.7×	232 0.8×	213 0.9×	99 0.7×	8 0.1×	68	676

Countries citing papers authored by Joel Wedd

Since Specialization

Citations

This map shows the geographic impact of Joel Wedd's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joel Wedd with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joel Wedd more than expected).

Fields of papers citing papers by Joel Wedd

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joel Wedd. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joel Wedd. The network helps show where Joel Wedd may publish in the future.

Co-authorship network of co-authors of Joel Wedd

This figure shows the co-authorship network connecting the top 25 collaborators of Joel Wedd. A scholar is included among the top collaborators of Joel Wedd based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joel Wedd. Joel Wedd is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Smirnova, Ekaterina A., Amon Asgharpour, Vaishali Patel, et al.. (2024). Utility of Lille Score in Predicting 30-Day Survival in Steroid-Treated Alcohol-Associated Hepatitis. Digestive Diseases and Sciences. 69(8). 3043–3050. 2 indexed citations

Lee, Hannah M., et al.. (2023). A narrative review of supportive and end of life care considerations in advanced hepatocellular carcinoma. Annals of Palliative Medicine. 12(6). 1260–1274. 3 indexed citations

Villalobos, Alexander, W. Wagstaff, Mian Guo, et al.. (2021). Predictors of Successful Yttrium‐90 Radioembolization Bridging or Downstaging in Patients with Hepatocellular Carcinoma. Canadian Journal of Gastroenterology and Hepatology. 2021(1). 9926704–9926704. 7 indexed citations

Villalobos, Alexander, W. Wagstaff, Minzhi Xing, et al.. (2020). Evaluation of Medium-Term Efficacy of Y90 Radiation Segmentectomy vs Percutaneous Microwave Ablation in Patients with Solitary Surgically Unresectable < 4 cm Hepatocellular Carcinoma: A Propensity Score Matched Study. CardioVascular and Interventional Radiology. 44(3). 401–413. 20 indexed citations

Wedd, Joel, et al.. (2020). The optimal timing and management of hepatitis B and C in patients with hepatocellular carcinoma. Chinese Clinical Oncology. 10(1). 4–4. 4 indexed citations

Kramer, Michael R., et al.. (2020). Variation in Racial Disparities in Liver Transplant Outcomes Across Transplant Centers in the United States. Liver Transplantation. 27(4). 558–567. 28 indexed citations

Akce, Mehmet, Yuan Liu, Katerina Zakka, et al.. (2020). Impact of Sarcopenia, BMI, and Inflammatory Biomarkers on Survival in Advanced Hepatocellular Carcinoma Treated With Anti-PD-1 Antibody. American Journal of Clinical Oncology. 44(2). 74–81. 46 indexed citations

Lopez‐Aguiar, Alexandra G., Rachel Lee, Lesley Miller, et al.. (2019). Optimizing cancer care for hepatocellular carcinoma at a safety‐net hospital: The value of a multidisciplinary disease management team. Journal of Surgical Oncology. 120(8). 1365–1370. 21 indexed citations

Zakka, Katerina, Renjian Jiang, Olatunji B. Alese, et al.. (2019). <p>Clinical outcomes of rare hepatocellular carcinoma variants compared to pure hepatocellular carcinoma</p>. Journal of Hepatocellular Carcinoma. Volume 6. 119–129. 15 indexed citations

10.

Wedd, Joel, Mohua Basu, Laura M. Curtis, et al.. (2019). Racial, Ethnic, and Socioeconomic Disparities in Web-Based Patient Portal Usage Among Kidney and Liver Transplant Recipients: Cross-Sectional Study. Journal of Medical Internet Research. 21(4). e11864–e11864. 27 indexed citations

11.

Zakka, Katerina, Renjian Jiang, Olatunji B. Alese, et al.. (2019). Clinical outcomes of hepatocellular carcinoma variants compared to hepatocellular carcinoma.. Journal of Clinical Oncology. 37(4_suppl). 435–435.

12.

Lopez‐Aguiar, Alexandra G., Lesley Miller, Sean R. Dariushnia, et al.. (2018). Optimizing cancer care for hepatocellular carcinoma at a safety-net hospital: the value of a multidisciplinary disease management team. HPB. 20. S81–S82. 5 indexed citations

13.

Pillai, Anjana, Joel Wedd, John P. Norvell, et al.. (2016). Simeprevir and Sofosbuvir (SMV–SOF) for 12 Weeks for the Treatment of Chronic Hepatitis C Genotype 1 Infection: A Real World (Transplant) Hepatology Practice Experience. The American Journal of Gastroenterology. 111(2). 250–260. 13 indexed citations

14.

Kalra, Avash, Joel Wedd, & Scott W. Biggins. (2016). Changing prioritization for transplantation. Current Opinion in Organ Transplantation. 21(2). 120–126. 41 indexed citations

15.

Halazun, Karim J., Amit K. Mathur, Abbas Rana, et al.. (2015). One Size Does Not Fit All—Regional Variation in the Impact of the Share 35 Liver Allocation Policy. American Journal of Transplantation. 16(1). 137–142. 25 indexed citations

16.

Wedd, Joel, et al.. (2014). Stage of Cirrhosis Predicts the Risk of Liver-Related Death in Patients With Low Model for End-Stage Liver Disease Scores and Cirrhosis Awaiting Liver Transplantation. Liver Transplantation. 20(10). 1193–1201. 35 indexed citations

17.

Wedd, Joel, Ann Harper, & Scott W. Biggins. (2013). MELD score, allocation, and distribution in the United States. Clinical Liver Disease. 2(4). 148–151. 20 indexed citations

18.

Smith, Jodi M., Scott W. Biggins, W. Ray Kim, et al.. (2012). Kidney, Pancreas and Liver Allocation and Distribution in the United States. American Journal of Transplantation. 12(12). 3191–3212. 77 indexed citations

19.

Kennedy, Marcus P., Raymond D. Coakley, Scott H. Donaldson, et al.. (2006). Burkholderia gladioli: Five year experience in a cystic fibrosis and lung transplantation center. Journal of Cystic Fibrosis. 6(4). 267–273. 52 indexed citations

20.

Muhlebach, Marianne S., Melissa B. Miller, Charity G. Moore, et al.. (2006). Are lower airway or throat cultures predictive of sinus bacteriology in cystic fibrosis?. Pediatric Pulmonology. 41(5). 445–451. 59 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact